VanEck Biotech ETF Rating $147.74 -0.89 (-0.60%) Closing price 03:57 PM EasternExtended Trading$147.68 -0.06 (-0.04%) As of 04:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Biotech ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBH Aggregate RatingModerate Buy 2.65Holdings in BBH have an aggregate rating of Moderate Buy based on 495 analyst ratings issued in the past year covering 25 companies (100.0% of the portfolio).BBH Aggregate Price Target$147.74High Prediction$147.74Average Prediction$147.74Low Prediction$147.74Holdings in BBH have an aggregate price target of $147.74 and a range of $147.74 to $147.74 covering 25 companies (100.0% of the portfolio).BBH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings16.28%AMGNAmgen$295.30+0.5%4.2687 of 5 stars2.48$314.91 6.6%23Analyst ForecastNews Coverage12.73%GILDGilead Sciences$105.68-0.8%4.5363 of 5 stars2.72$105.12 -0.5%29Positive News11.18%VRTXVertex Pharmaceuticals$500.49+0.9%4.0986 of 5 stars2.64$512.41 2.4%25Short Interest ↓Analyst RevisionPositive News5.18%REGNRegeneron Pharmaceuticals$557.91-2.3%4.8718 of 5 stars2.77$964.88 72.9%26Analyst ForecastPositive News5.13%ARGXargenx$605.38-0.2%3.2573 of 5 stars2.91$690.33 14.0%234.55%NTRANatera$151.74+2.2%3.0879 of 5 stars3.00$175.76 15.8%16Positive News4.40%IQVIQVIA$149.14-1.2%4.9213 of 5 stars2.82$241.50 61.9%22Short Interest ↓4.39%ALNYAlnylam Pharmaceuticals$230.93-3.8%4.562 of 5 stars2.77$315.58 36.7%263.47%ICLRICON Public$145.16-1.1%3.972 of 5 stars2.67$232.67 60.3%15Analyst DowngradeShort Interest ↑Gap Down3.30%BIIBBiogen$116.98-1.9%4.6943 of 5 stars2.42$213.15 82.2%31Analyst Revision2.91%ITCIIntra-Cellular Therapies$131.873.4948 of 5 stars2.33$106.23 -19.4%15Analyst ForecastPositive News2.80%ILMNIllumina$74.59-0.6%4.6532 of 5 stars2.48$138.70 85.9%21News Coverage2.50%INSMInsmed$71.07+0.1%4.1144 of 5 stars3.00$94.00 32.3%16Positive News2.39%BNTXBioNTech$99.00-3.3%2.695 of 5 stars2.89$143.44 44.9%18Positive News2.24%ONCBeigene$238.84-1.6%2.2987 of 5 stars3.00$316.67 32.6%3Gap Down2.15%NBIXNeurocrine Biosciences$96.16+1.3%4.8388 of 5 stars2.91$161.86 68.3%23Analyst UpgradeNews CoveragePositive NewsGap Up2.13%MRNAModerna$26.24-2.1%4.3298 of 5 stars2.04$58.70 123.7%24Gap Down1.89%TECHBio-Techne$51.07-2.8%4.8998 of 5 stars2.44$81.25 59.1%9Positive News1.80%BMRNBioMarin Pharmaceutical$60.02+0.6%4.887 of 5 stars2.71$94.00 56.6%24Positive News1.70%INCYIncyte$58.46-1.3%4.8613 of 5 stars2.21$74.88 28.1%191.52%CRLCharles River Laboratories International$106.02-0.5%4.7637 of 5 stars1.94$182.00 71.7%16Short Interest ↓Analyst RevisionNews CoverageHigh Trading Volume1.52%QGENQiagen$41.52-1.9%3.4768 of 5 stars2.27$47.71 14.9%11High Trading Volume1.36%RGENRepligen$126.62-0.5%4.7422 of 5 stars2.57$178.64 41.1%14Positive News1.28%EXASExact Sciences$43.67-1.3%4.2259 of 5 stars2.95$69.25 58.6%221.21%SRPTSarepta Therapeutics$54.42-0.4%4.6739 of 5 stars2.83$161.83 197.4%24Short Interest ↑ This page (NASDAQ:BBH) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BBH Stock Free BBH Stock Alerts